US Patent Issued to Gambro Lundia on Jan. 20 for "Renal failure therapy systems having reduced time between treatments" (Swedish Inventors)

ALEXANDRIA, Va., Jan. 20 -- United States Patent no. 12,527,899, issued on Jan. 20, was assigned to Gambro Lundia AB (Lund, Sweden).

"Renal failure therapy systems having reduced time between treatments" was invented by Per-Olof Borgqvist (Lund, Sweden) and Olof Jansson (Vellinge, Sweden).

According to the abstract* released by the U.S. Patent & Trademark Office: "A renal failure therapy system includes a fresh dialysis fluid tube having a connector for connecting to a dialyzer, a spent dialysis fluid tube having a connector for connecting to the dialyzer, a dialysis fluid circuit including a fresh dialysis fluid line, a spent dialysis fluid line, at least one of (i) a first disinfection device positioned between the fresh dialysis fluid ...